Barclays’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-13,500
| Closed | -$3.74M | – | 5251 |
|
|
2020
Q3 | $3.74M | Buy |
+13,500
| New | +$3.89M | ﹤0.01% | 1603 |
|
|
2020
Q2 | – | Sell |
-1,300
| Closed | -$189K | – | 6461 |
|
|
2020
Q1 | $189K | Sell |
1,300
-26,200
| -95% | -$4.35M | ﹤0.01% | 4346 |
|
|
2019
Q4 | $4.69M | Buy |
27,500
+26,200
| +2,015% | +$4.86M | 0.01% | 2068 |
|
|
2019
Q3 | $231K | Sell |
1,300
-29,700
| -96% | -$6.42M | ﹤0.01% | 4862 |
|
|
2019
Q2 | $8.07M | Buy |
+31,000
| New | +$8.23M | 0.01% | 1496 |
|
|
2019
Q1 | – | Sell |
-2,200
| Closed | -$715K | – | 7463 |
|
|
2018
Q4 | $715K | Buy |
2,200
+2,000
| +1,000% | +$695K | ﹤0.01% | 3457 |
|
|
2018
Q3 | $90K | Buy |
+200
| New | +$78.8K | ﹤0.01% | 5648 |
|
|
2018
Q2 | – | Sell |
-1,200
| Closed | -$349K | – | 7432 |
|
|
2018
Q1 | $349K | Buy |
1,200
+200
| +20% | +$50.7K | ﹤0.01% | 4323 |
|
|
2017
Q4 | $187K | Buy |
+1,000
| New | +$187K | ﹤0.01% | 4748 |
|
|
2014
Q4 | – | Sell |
-1,200
| Closed | -$29K | – | 7713 |
|
|
2014
Q3 | $29K | Sell |
1,200
-300
| -20% | -$7.6K | ﹤0.01% | 6252 |
|
|
2014
Q2 | $38K | Buy |
1,500
+1,200
| +400% | +$27.9K | ﹤0.01% | 6137 |
|
|
2014
Q1 | $8K | Buy |
+300
| New | +$8.3K | ﹤0.01% | 7039 |
|
|
2013
Q4 | – | Sell |
-200
| Closed | -$4K | – | 7761 |
|
|
2013
Q3 | $4K | Sell |
200
-4,700
| -96% | -$107K | ﹤0.01% | 7056 |
|
|
2013
Q2 | $106K | Buy |
+4,900
| New | +$98.5K | ﹤0.01% | 5746 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB